Preventing Weight Gain in Children with ALL: The PEDALL Study
This study is testing an intervention called PEDALL, a six-month nutrition education program delivered online, to help prevent children and adolescents with acute lymphoblastic leukemia (ALL) from becoming overweight or obese during their maintenance chemotherapy. Many children with ALL gain weight during treatment, which can lead to health problems later. The PEDALL program, offered in English and Spanish, aims to teach families about healthy eating. You could be eligible if you are 5 to 21 years old, are receiving or will receive maintenance chemotherapy for ALL, and can start the program within the first month of this treatment phase. The study will measure if PEDALL is more effective than standard nutrition care at preventing overweight or obesity over 3.5 years.
- Study design
- This interventional study plans to enroll 376 participants. Participants will be randomly assigned to either receive the PEDALL intervention or standard nutrition education.
- What's involved
- If you are in the PEDALL group, you will receive 26 hours of specialized nutrition education and counseling online over six months.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed for 3.5 years to see the long-term effects of the intervention.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
A Bilingual Virtually-based Intervention (PEDALL) for the Prevention of Weight Gain in Childhood ALL Patients Considering Key Genetic and Sociodemographic Risk Factors
At a glance
Conditions
NCT05963971
Where you'd take part
This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
Columbia University Medical Center
New York, New Yorkstudy coordinator listed
Recruiting
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Study leadership
- Elena Ladas, PhD, RD · PRINCIPAL_INVESTIGATOR · Columbia University
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Want this trial checked against your situation?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- To prevent the development of OW/OB during maintenance chemotherapy using a six-month virtually delivered dietary education intervention (PEDALL) in English and Spanish speaking families of children and adolescents undergoing treatment for ALL.3.5 years
Number of participants with overweight or obesity as assessed by body mass index (BMI) for age z-scores \>1 will change from baseline following 6 month virtual diet education intervention. BMI z-score will be evaluated at the end of 6-month intervention in the maintenance phase of ALL therapy. BMI z-scores will be classified by comparing age, sex, height and weight to CDC growth charts. OW is defined as BMI z-score ≥ +1.04 , and OB is defined as BMI z-score ≥ +1.645 . For participants ≥20 years of age, adult classifications will be used to determine weight status as recommended by the CDC and include BMI \< 19 underweight; BMI 19-\<25 healthy weight; BMI ≥ 25 - \<30 overweight; BMI ≥ 30 obese.